Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Lack of glucocorticoid receptor activation by formoterol and salmeterol in human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003
Combination of budesonide and formoterol is more effective in inhibiting GM-CSF production by bronchial epithelial cells than either drug alone Source: Eur Respir J 2003; 22: Suppl. 45, 457s Year: 2003
Budesonide esterification in human bronchial epithelial cells is not impaired by formoterol Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Inhibitory effects of formoterol, budesonide and tiotropium bromide on human neutrophils in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003
Anti-inflammatory effect of beclomethasone dipropionate and formoterol on TNF-α-induced human endothelial cell activation Source: Annual Congress 2011 - Lung cell biology Year: 2011
Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells Source: Eur Respir J 2008; 31: 1313-1321 Year: 2008
Multiple synergistic effects of fluticasone propionate and salmeterol on T-cell activation in bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 250s Year: 2004
Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015
Role of budesonide, formoterol fumarate and aclidinium bromide in the inflammaging of airway epithelial cells Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017
Additive blockade of β2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate Source: Eur Respir J 2004; 24: 333 Year: 2004
Effects of fluticasone and salmeterol on cytokine-induced airway smooth muscle IP10 release Source: Eur Respir J 2005; 26: Suppl. 49, 712s Year: 2005
Budesonide and formoterol inhibit bronchial epithelial cell-mediated eosinophil superoxide production Source: Eur Respir J 2005; 26: Suppl. 49, 123s Year: 2005
Attenuating effect of tiotropium bromide on IL-8 production from human bronchial epithelial cells, BEAS-2B in vitro Source: Annual Congress 2009 - Epithelial cell biology Year: 2009
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004